SI1023898T1 - Cyano-indoles as serotonine reuptake inhibitors and as 5-HT2c receptor ligands - Google Patents
Cyano-indoles as serotonine reuptake inhibitors and as 5-HT2c receptor ligandsInfo
- Publication number
- SI1023898T1 SI1023898T1 SI200030063T SI200030063T SI1023898T1 SI 1023898 T1 SI1023898 T1 SI 1023898T1 SI 200030063 T SI200030063 T SI 200030063T SI 200030063 T SI200030063 T SI 200030063T SI 1023898 T1 SI1023898 T1 SI 1023898T1
- Authority
- SI
- Slovenia
- Prior art keywords
- alkyl
- cycloalkyl
- indoles
- cyano
- receptor ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9900801A FR2788772B1 (fr) | 1999-01-26 | 1999-01-26 | Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP00400193A EP1023898B1 (fr) | 1999-01-26 | 2000-01-26 | Cyano-indoles en tant qu' inhibiteurs de recapture de sérotonine et ligands du récepteur 5-HT2c |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1023898T1 true SI1023898T1 (en) | 2003-06-30 |
Family
ID=9541208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200030063T SI1023898T1 (en) | 1999-01-26 | 2000-01-26 | Cyano-indoles as serotonine reuptake inhibitors and as 5-HT2c receptor ligands |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6239129B1 (es) |
| EP (1) | EP1023898B1 (es) |
| JP (1) | JP2000212162A (es) |
| KR (1) | KR100445389B1 (es) |
| CN (1) | CN1155570C (es) |
| AT (1) | ATE234093T1 (es) |
| AU (1) | AU761084B2 (es) |
| BR (1) | BR0000158A (es) |
| CA (1) | CA2297279C (es) |
| DE (1) | DE60001591T2 (es) |
| DK (1) | DK1023898T3 (es) |
| EA (1) | EA003146B1 (es) |
| ES (1) | ES2193923T3 (es) |
| FR (1) | FR2788772B1 (es) |
| HK (1) | HK1029584A1 (es) |
| HU (1) | HUP0000308A2 (es) |
| MX (1) | MXPA00000856A (es) |
| NO (1) | NO314801B1 (es) |
| NZ (1) | NZ502494A (es) |
| PL (1) | PL338027A1 (es) |
| SI (1) | SI1023898T1 (es) |
| ZA (1) | ZA200000336B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001247562A (ja) * | 2000-03-07 | 2001-09-11 | Daicel Chem Ind Ltd | アミド化合物及びその製造方法 |
| SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
| CA2448729A1 (en) * | 2000-11-20 | 2002-05-23 | Biovitrum Ab | Piperazinyl and piperidyl substituted heterocyclic compounds |
| CZ20032644A3 (en) | 2001-03-29 | 2004-06-16 | Bristol-Myers Squibb Company | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| RU2327685C2 (ru) * | 2002-09-17 | 2008-06-27 | Ф.Хоффманн-Ля Рош Аг | 2,7-замещенные индолы и фармацевтическая композиция, проявляющая антагонистическую активность по отношению к 5-гт6 рецептору |
| US7129264B2 (en) * | 2003-04-16 | 2006-10-31 | Bristol-Myers Squibb Company | Biarylmethyl indolines and indoles as antithromboembolic agents |
| EP1689389A4 (en) * | 2003-12-04 | 2009-06-17 | Nat Health Research Institutes | Indole compounds |
| FR2884251B1 (fr) * | 2005-04-08 | 2007-07-13 | Servier Lab | Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK181190D0 (da) * | 1990-07-30 | 1990-07-30 | Lundbeck & Co As H | 3-aryl-indol- eller 3-aryl-indazolderivater |
| TW270114B (es) * | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
| DE19500689A1 (de) * | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
| US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| WO1998030548A1 (fr) * | 1997-01-13 | 1998-07-16 | Yamanouchi Pharmaceutical Co., Ltd. | AGONISTES DU RECEPTEUR 5-HT2c ET DERIVES D'AMINOALKYLINDAZOLE |
-
1999
- 1999-01-26 FR FR9900801A patent/FR2788772B1/fr not_active Expired - Fee Related
-
2000
- 2000-01-24 CA CA002297279A patent/CA2297279C/fr not_active Expired - Fee Related
- 2000-01-24 JP JP14544A patent/JP2000212162A/ja active Pending
- 2000-01-25 AU AU13553/00A patent/AU761084B2/en not_active Ceased
- 2000-01-25 EA EA200000068A patent/EA003146B1/ru not_active IP Right Cessation
- 2000-01-25 NO NO20000373A patent/NO314801B1/no unknown
- 2000-01-25 US US09/490,909 patent/US6239129B1/en not_active Expired - Fee Related
- 2000-01-25 BR BR0000158-9A patent/BR0000158A/pt not_active Withdrawn
- 2000-01-25 PL PL00338027A patent/PL338027A1/xx not_active Application Discontinuation
- 2000-01-25 NZ NZ502494A patent/NZ502494A/en unknown
- 2000-01-25 KR KR10-2000-0003388A patent/KR100445389B1/ko not_active IP Right Cessation
- 2000-01-25 MX MXPA00000856A patent/MXPA00000856A/es not_active IP Right Cessation
- 2000-01-26 ZA ZA200000336A patent/ZA200000336B/xx unknown
- 2000-01-26 EP EP00400193A patent/EP1023898B1/fr not_active Expired - Lifetime
- 2000-01-26 HU HU0000308A patent/HUP0000308A2/hu unknown
- 2000-01-26 AT AT00400193T patent/ATE234093T1/de not_active IP Right Cessation
- 2000-01-26 DE DE60001591T patent/DE60001591T2/de not_active Expired - Fee Related
- 2000-01-26 ES ES00400193T patent/ES2193923T3/es not_active Expired - Lifetime
- 2000-01-26 SI SI200030063T patent/SI1023898T1/xx unknown
- 2000-01-26 DK DK00400193T patent/DK1023898T3/da active
- 2000-01-26 CN CNB001011561A patent/CN1155570C/zh not_active Expired - Fee Related
-
2001
- 2001-01-12 HK HK01100310A patent/HK1029584A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2193923T3 (es) | 2003-11-16 |
| ATE234093T1 (de) | 2003-03-15 |
| HUP0000308A2 (en) | 2002-06-29 |
| DE60001591T2 (de) | 2003-12-24 |
| FR2788772A1 (fr) | 2000-07-28 |
| NO314801B1 (no) | 2003-05-26 |
| CN1266057A (zh) | 2000-09-13 |
| EA200000068A2 (ru) | 2000-08-28 |
| AU1355300A (en) | 2000-07-27 |
| US6239129B1 (en) | 2001-05-29 |
| EA200000068A3 (ru) | 2000-10-30 |
| HU0000308D0 (en) | 2000-03-28 |
| AU761084B2 (en) | 2003-05-29 |
| NO20000373D0 (no) | 2000-01-25 |
| EA003146B1 (ru) | 2003-02-27 |
| MXPA00000856A (es) | 2002-03-08 |
| KR100445389B1 (ko) | 2004-08-25 |
| EP1023898A1 (fr) | 2000-08-02 |
| HK1029584A1 (en) | 2001-04-06 |
| NO20000373L (no) | 2000-07-27 |
| CA2297279C (fr) | 2004-05-18 |
| NZ502494A (en) | 2001-06-29 |
| CA2297279A1 (fr) | 2000-07-26 |
| FR2788772B1 (fr) | 2001-03-02 |
| BR0000158A (pt) | 2000-09-19 |
| KR20010006587A (ko) | 2001-01-26 |
| DE60001591D1 (de) | 2003-04-17 |
| PL338027A1 (en) | 2000-07-31 |
| EP1023898B1 (fr) | 2003-03-12 |
| CN1155570C (zh) | 2004-06-30 |
| JP2000212162A (ja) | 2000-08-02 |
| DK1023898T3 (da) | 2003-06-10 |
| ZA200000336B (en) | 2000-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP055644A (es) | Derivados de la quinolil-propil-piperidina y su utilización | |
| TW342390B (en) | Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents | |
| SI1023898T1 (en) | Cyano-indoles as serotonine reuptake inhibitors and as 5-HT2c receptor ligands | |
| AU9079198A (en) | Indolecarboxylic compounds and their use as pharmaceutical compounds | |
| ECSP930953A (es) | Nuevos derivados de indol | |
| WO2000066546A3 (en) | Monofluoroalkyl derivatives | |
| TW356468B (en) | Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same | |
| BR0208823A (pt) | Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica | |
| MXPA02003952A (es) | Derivados de imidazol como inhibidores de la fosfodieterasa vii. | |
| NO20053302D0 (no) | Imidazolderivater med affinitet for alfa 2-reseptoraktivitet. | |
| AU1597092A (en) | 2-piperazinylbenzimidazole derivatives and processes for the preparation thereof | |
| BG106048A (en) | 6-[[(aryl and heteroaryl)oxy]methyl]naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof | |
| ZA200002151B (en) | 1-AZA-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| NO955071L (no) | abeo-Ergolin-derivater som 5HT1A-ligander | |
| ES2182775T3 (es) | Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion. | |
| NO20021162D0 (no) | 5-aminoalkyl og 5-aminokarbonyl-substituerte indoler | |
| AU6520498A (en) | Process for producing piperidinecarboxylic acid amides |